Tempest Therapeutics (TPST) Assets (QoQ) (2012 - 2025)
Tempest Therapeutics (TPST) Assets (QoQ) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.39 Bn | 132.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.47 Bn | 78.47 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.25 Bn | 60.07 Bn | 1.37 Bn |
| 4 | Moderna | 61.79 Bn | 56.66 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.27 Bn | 37.17 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.17 Bn | 27.86 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.61 Bn | 10.22 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.46 Bn | - |
| 10 | Tempest Therapeutics | 4.38 Mn | 3.58 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.16% |
| Sep 30, 2025 | -30.04% |
| Jun 30, 2025 | -23.88% |
| Mar 31, 2025 | -22.47% |
| Dec 31, 2024 | 22.61% |
| Sep 30, 2024 | -19.76% |
| Jun 30, 2024 | -4.98% |
| Mar 31, 2024 | -14.00% |
| Dec 31, 2023 | 115.13% |
| Sep 30, 2023 | -21.97% |
| Jun 30, 2023 | -17.65% |
| Mar 31, 2023 | -19.01% |
| Dec 31, 2022 | -27.04% |
| Sep 30, 2022 | -11.46% |
| Jun 30, 2022 | 6.57% |
| Mar 31, 2022 | -8.58% |
| Dec 31, 2021 | 9.08% |
| Sep 30, 2021 | -11.07% |
| Jun 30, 2021 | 3.08% |
| Mar 31, 2021 | 220.33% |